The Oncology Institute, Inc.
The Oncology Institute, Inc. (TOI) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · TOI · as of Sep 30, 2025
Ownership Breakdown
114
Institutional Holders
▲ 35 vs Q2
$120.99M
Total Inst. Value
▲ $55.52M vs Q2
99.98M
Shares Outstanding
freeFloat 49.41%
34.67M
13F Shares Held
▲ 2.73M vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
TOI largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
VANGUARD GROUP INC services-offices & clinics of doctors of medicine | 4.55M | 48.77% | 48.77% | $15.86B | Nov 7, 2025 | ▲ 264.4K |
BLACKROCK, INC. services-offices & clinics of doctors of medicine | 3.43M | 36.85% | 36.85% | $11.99B | Nov 12, 2025 | ▲ 128.0K |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) services-offices & clinics of doctors of medicine | 3.36M | 36.05% | 36.05% | $11.73B | Nov 14, 2025 | — held |
CENTERBOOK PARTNERS LP services-offices & clinics of doctors of medicine | 2.70M | 29.02% | 29.02% | $9.44B | Nov 7, 2025 | ▲ 1.99M |
BALYASNY ASSET MANAGEMENT L.P. services-offices & clinics of doctors of medicine | 2.52M | 27.02% | 27.02% | $8.79B | Nov 14, 2025 | — held |
KANEN WEALTH MANAGEMENT LLC services-offices & clinics of doctors of medicine | 1.84M | 19.76% | 19.76% | $6.42B | Nov 14, 2025 | NEW |
WEXFORD CAPITAL LP services-offices & clinics of doctors of medicine | 1.57M | 16.86% | 16.86% | $5.48B | Nov 14, 2025 | ▲ 452.4K |
GEODE CAPITAL MANAGEMENT, LLC services-offices & clinics of doctors of medicine | 1.40M | 15.04% | 15.04% | $4.89B | Nov 12, 2025 | ▲ 122.5K |
STATE STREET CORP services-offices & clinics of doctors of medicine | 1.13M | 12.12% | 12.12% | $3.94B | Nov 14, 2025 | ▲ 483.8K |
UBS GROUP AG services-offices & clinics of doctors of medicine | 1.06M | 11.33% | 11.33% | $3.68B | Nov 13, 2025 | ▲ 635.5K |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
20
Increased
+6.61M shares14
New Positions
first time holders9
Decreased
−5.42M shares0
Sold Out
fully exitedNet shares change (top 50)
+1.19M
+6.61M / −5.42M
Net new holders
+25
14 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
TOI insider trading · insider activity
Source: SEC Form 4
Insiders have been net buyers of shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
5
Buy transactions
5
Sell transactions
1.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Chernett Jorey 10 percent owner | Jun 4, 2026 | Purchase | 12,000 | $4.75 | $57.0K | 10.58M | Form 4 ↗ |
Podnos Yale Chief Medical Officer | May 21, 2026 | J-Other | 1,805 | $4.47 | $8.1K | 283.0K | Form 4 ↗ |
Virnich Daniel Chief Executive Officer | May 21, 2026 | J-Other | 23,058 | $4.47 | $103.1K | 2.34M | Form 4 ↗ |
Carter Robert Ross Chief Financial Officer | May 21, 2026 | J-Other | 1,604 | $4.47 | $7.2K | 414.8K | Form 4 ↗ |
Chernett Jorey 10 percent owner | May 20, 2026 | Purchase | 33,500 | $4.07 | $136.3K | 10.57M | Form 4 ↗ |
Chernett Jorey 10 percent owner | May 19, 2026 | Purchase | 5,000 | $4.05 | $20.3K | 10.53M | Form 4 ↗ |
Chernett Jorey 10 percent owner | May 19, 2026 | Purchase | 30,000 | $4.09 | $122.7K | 10.53M | Form 4 ↗ |
Kaushal Mohit director | Apr 14, 2026 | Sale | 57,286 | $3.50 | $200.6K | 211.0K | Form 4 ↗ |
Kaushal Mohit director | Apr 16, 2026 | Sale | 38,433 | $3.50 | $134.5K | 172.6K | Form 4 ↗ |
Chernett Jorey 10 percent owner | Apr 9, 2026 | Purchase | 20,000 | $3.10 | $62.0K | 10.50M | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
The Oncology Institute, Inc. (TOI) is primarily owned by institutional investors, who hold approximately 34.7% of total shares outstanding. Company insiders own approximately 50.59%, while retail and public investors account for the remaining 14.73%.
The largest institutional shareholder of The Oncology Institute, Inc. is VANGUARD GROUP INC, holding approximately 4.55 million shares — equal to 48.77% of outstanding shares — as of September 30, 2025.
A total of 114 institutional investors currently hold TOI stock, with a combined institutional value of approximately $120,993,806 as of the most recent 13F filing period.
Frequently asked questions
TOI ownershipThe Oncology Institute, Inc. (TOI) is primarily owned by institutional investors, who hold approximately 34.7% of shares. The largest shareholder is VANGUARD GROUP INC with a 48.77% stake. Company insiders hold 50.59%. Data sourced from SEC Form 13F as of September 30, 2025.